Albin Moschner - Nuveen Amt-free Independent Director
NUW Fund | USD 13.86 0.06 0.43% |
Age | 69 |
Tenure | 8 years |
Phone | 312 917 7700 |
Web | https://www.nuveen.com/CEF/Product/Overview.aspx?FundCode=NUW&refsrc=vu_nuveen.com/nuw |
Albin Moschner Latest Insider Activity
Tracking and analyzing the buying and selling activities of Albin Moschner against Nuveen Amt-free fund is an integral part of due diligence when investing in Nuveen Amt-free. Albin Moschner insider activity provides valuable insight into whether Nuveen Amt-free is net buyers or sellers over its current business cycle. Note, Nuveen Amt-free insiders must abide by specific rules, including filing SEC forms every time they buy or sell Nuveen Amt-free'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Albin Moschner over three months ago Insider Trading | ||
Albin Moschner over six months ago Insider Trading |
Nuveen Amt-free Management Performance (%)
Similar Money Managers
Showing other executives | One Year Return | ||
Brian Lockhart | Nuveen New York | 47 | |
Stayce Harris | Blackrock Enhanced Capital | N/A | |
Mark Winget | Nuveen New York | 53 | |
Marcus Smith | Eaton Vance New | 53 | |
Thomas Kent | Tekla Life Sciences | 67 | |
Margaret Wolff | Nuveen Mortgage Opportunity | 66 | |
Payson CFA | Eaton Vance New | N/A | |
Laura Woodward | Tekla Life Sciences | 51 | |
Jacques Longerstaey | Nuveen Mortgage Opportunity | 58 | |
Mark Fetting | Eaton Vance New | 65 | |
Brian Lockhart | Nuveen Mortgage Opportunity | 47 | |
Jeffrey Bailey | Tekla Healthcare Investors | 58 | |
Mark Winget | Nuveen Mortgage Opportunity | 53 | |
E Wickerham | Nuveen Mortgage Opportunity | 47 | |
Catherine Lynch | Blackrock Enhanced Capital | 60 | |
Todd Kuehl | Western Asset High | 50 | |
Keith Quinton | Eaton Vance New | 61 | |
Matthew Thornton | Nuveen New York | 63 | |
Richard Froio | Eaton Vance New | 51 | |
Nathaniel Jones | Nuveen Mortgage Opportunity | 42 | |
Michael Perry | Nuveen New York | 53 |
Nuveen Amt Free Leadership Team
Elected by the shareholders, the Nuveen Amt-free's board of directors comprises two types of representatives: Nuveen Amt-free inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Nuveen. The board's role is to monitor Nuveen Amt-free's management team and ensure that shareholders' interests are well served. Nuveen Amt-free's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Nuveen Amt-free's outside directors are responsible for providing unbiased perspectives on the board's policies.
Mark Winget, Vice President Assistant Secretary | ||
E Wickerham, Vice President Controller | ||
Robert Young, Independent Director | ||
Deann Morgan, Vice President | ||
Jack Evans, Independent Director | ||
David Lamb, Chief Administrative Officer | ||
Cedric Antosiewicz, Chief Administrative Officer | ||
Judith Stockdale, Independent Director | ||
William Siffermann, Vice President | ||
William Meyers, Vice President | ||
Michael Perry, Vice President | ||
Jacques Longerstaey, Vice President | ||
Matthew Thornton, Independent Director | ||
Margaret Wolff, Independent Director | ||
Brian Lockhart, Vice President | ||
Margo Cook, Vice President | ||
Joel Slager, Vice President Assistant Secretary | ||
Gifford Zimmerman, Chief Compliance Officer, Vice President | ||
Nathaniel Jones, Vice President Treasurer | ||
Terence Toth, Independent Chairman of the Board | ||
Carole Stone, Independent Director | ||
Jon Meissner, Vice President | ||
Christopher Rohrbacher, Vice President Assistant Secretary | ||
Joanne Medero, Independent Director | ||
Walter Kelly, Chief Compliance Officer, Vice President | ||
John Nelson, Independent Director | ||
Albin Moschner, Independent Director | ||
Amy Lancellotta, Independent Director | ||
Kevin McCarthy, Vice President, Assistant Secretary | ||
William Hunter, Independent Director | ||
Tina Lazar, Vice President |
Nuveen Fund Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right fund is not an easy task. Is Nuveen Amt-free a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Shares Outstanding | 17.95 M | |||
Shares Owned By Insiders | 0.04 % | |||
Shares Owned By Institutions | 33.53 % | |||
Number Of Shares Shorted | 17.88 K | |||
Price To Earning | 13.39 X | |||
Short Ratio | 0.44 X | |||
Earnings Per Share | 0.99 X | |||
Number Of Employees | 21 | |||
Beta | 0.05 | |||
Market Capitalization | 260.47 M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Nuveen Fund
Nuveen Amt-free financial ratios help investors to determine whether Nuveen Fund is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Nuveen with respect to the benefits of owning Nuveen Amt-free security.
Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |